Dengue Vaccine (QDENGA)

• About

  

• appointment

  

Dengue fever is an infectious disease caused by the dengue virus, transmitted to humans through mosquito bites. Symptoms generally manifest 3 to 7 days after infection, including high fever, rash, headaches, joint and muscle pain, as well as nausea and vomiting. A minority of patients may experience severe complications, such as dengue hemorrhagic fever or dengue shock syndrome. Without timely and appropriate medical intervention, these serious conditions can be fatal.

Since 2017, Indonesia has reported dengue fever infections ranging from a low of 65,000 cases in 2018 to a high of 143,000 cases in 2022. As of July 1, 2024, there have been 149,866 confirmed cases of dengue fever, which is approximately three times higher than the same period in 2023. Cases have been reported from 465 districts across all 38 provinces, with 884 confirmed deaths.

Source：dengue

Vaccination against dengue fever can provide a significant level of protection. It has been reported that receiving the dengue vaccine (QDENGA) a specified number of times can reduce the risk of hospitalization due to dengue virus infection by 84% and the incidence of dengue fever by 61%. In addition to vaccination, it is important to take precautions when staying in areas with mosquitoes, such as wearing long sleeves and long pants, and using mosquito repellent (like sprays) to avoid bites.

Eligible age for vaccination：6 to 45 years
Number of doses ：2 (the second dose is administered 3 months after the first dose).